This inventor holds 1 USPTO granted patent. Top assignee: Xenon Pharmaceuticals Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Y Paul Goldberg: Innovator in Human Elongase Genes
Introduction
Y Paul Goldberg is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of genetics, particularly in the area of human elongase genes. His work focuses on the identification and application of these genes in medical treatments.
Latest Patents
Goldberg holds a patent for "Human elongase genes and uses thereof." This invention relates to elongase genes, their polypeptides, and their control regions. The patent outlines the use of these genes and polypeptides in developing compositions for treating diseases. The identified compositions are designed to regulate the expression of elongase genes or modulate the activity of their protein products. The patent also provides nucleotide and amino acid sequences for ELG4, ELG6, and ELG7, along with the control sequences and functions for ELG1 through ELG7.
Career Highlights
Goldberg is associated with Xenon Pharmaceuticals Inc., where he continues to advance his research in genetics. His work has the potential to impact therapeutic approaches in treating various diseases.
Collaborations
Some of his notable coworkers include Andre Ponton and Michael D Winther, who contribute to the innovative environment at Xenon Pharmaceuticals Inc.
Conclusion
Y Paul Goldberg's contributions to the field of genetics, particularly through his patent on human elongase genes, highlight his role as an innovator in medical research. His work continues to pave the way for advancements in disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile